Author Archives: Delaina Hawkins

Delaina Hawkins

About Delaina Hawkins

Delaina Hawkins, Director of Marketing & Business Development at Golden Helix, joined the team in June of 2017. She is passionate about elevating a company to effectively grow user engagement, build brand loyalty and ultimately drive sales and revenue. When she isn't in the office, she enjoys being outdoors with friends and family.

2020 T-Shirt Design Competition Winners

         September 8, 2020
T-Shirt Design Competition

We would like to thank everyone who participated in our 2020 t-shirt design competition. It was great to see the amount of creativity our community expressed and was certainly a tough decision to make! We are pleased to announce this year’s winners: First Place – Michaela Lucas Michaela Lucas is a senior graphic design student at The Pennsylvania State University…. Read more »

Case Study with the Rutgers Cancer Institute of New Jersey: Researching the Impact of HLA on COVID-19 Patients with SNP & Variation Suite

         August 8, 2020

The COVID-19 Pandemic ferociously spread across the globe bringing our daily lives to a quick halt – desks, streets, and towns nearly empty as our world united together to help “flatten the curve”. While most of us were introduced to remote work, medical workers from all different specialties were called upon to help treat and test COVID-19 patients. One long… Read more »

Golden Helix Featured in Various Publications

         July 8, 2020

Golden Helix has been incredibly fortunate to have been featured in a variety of publications over these last six months. Topics span from the history and future of our company to several new use cases for our solutions that extend into the infectious disease space, recently coming to fruition with the COVID-19 pandemic. We are so grateful to have received… Read more »

Golden Helix’s 2020 T-Shirt Competition Begins

         June 23, 2020

It’s everyone’s favorite time of the year; Golden Helix’s Annual T-Shirt Design Competition is starting! If you’d like to participate, simply send a sketch of your design to marketing@goldenhelix.com. Don’t forget about the sweet prizes we’re handing out for the top three designs: First Place: $300 Second Place: $200 Third Place: $100 Deadline: August 25, 2020 How It Works Draw it… Read more »

CADD Scores: New and Improved v1.4 and v1.5

         June 18, 2020

The University of Washington’s Combined Annotation Dependent Depletion (CADD) algorithm measures the deleteriousness of genetic variants. This includes single nucleotide polymorphisms (SNVs) and short insertions and deletions (indels) throughout the human reference genome assembly. This algorithm was introduced in 2014 and has since become one of the most widely used tools to assess human genetic variation. Since 2014, the algorithm has been… Read more »

Golden Helix Named as Top 10 Genetic Diagnostics Companies of 2020

         May 28, 2020

Today, Healthcare Tech Outlook announced its collection of the Top 10 Genetic Diagnostics Companies of 2020. We are incredibly honored to have received this award and being recognized amongst the top biotech companies! If you are interested in reading our story, and why we were selected for this award, you can access the publication here: https://genetic.healthcaretechoutlook.com/vendor/golden-helix-bioinformatics-for-advanced-life-science-research-cid-1369-mid-128.html. As always, we would not be… Read more »

Golden Helix Releases Discounted Pricing for Select Packages

         May 12, 2020

Golden Helix has been committed to making sure our community has the tools and resources they need during this pandemic. We have developed several different assistance programs, such as our home office licenses for current users and our software discounts for COVID-19 related projects, to name a few. We have been approached by a number of labs not working with COVID-19… Read more »

Webcast Recap: Drugs & Trials for Cancer Diagnostics

         March 5, 2020

Introducing Drugs & Trials for Cancer Diagnostics VSClinical offers enormous simplicity and consistency in evaluating biomarkers and providing treatment options. Last month, we announced our newest feature to now include the automated collection of relevant clinical trials. The new capability was unveiled in our “Introducing Drugs & Trials for Cancer Diagnostics” webcast with Nathan Fortier, Ph.D., Director of Research, showing… Read more »

Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web

         February 11, 2020

We are incredibly grateful to be recognized as one of the Top 60 Genetics Blogs on the Web by Feedspot. Our team is dedicated to educating our readers on how our solutions can help enable precision medicine, and we are so honored to have received this recognition.  On our blog, you will discover posts touching on important topics, like cyber security strategies,… Read more »

Off to PAG XXVIII!

         January 7, 2020

We’re packing our bags and getting ready to head out to San Diego, CA for the International Plant & Animal Genome XXVIII meeting (or PAG 2020). This is the largest ag-genomics meeting in the world, bringing together over 3,000 leading genetic scientists and researchers in plant and animal research, and over 120 exhibits, 140+ workshops, 1000+ posters, and 1700+ abstracts. We… Read more »

End of Year Bundles 2019

         November 12, 2019

It’s the most wonderful time of the year; our software specials are here! Now is the time to implement a Golden Helix solution to automate your workflows and analyze variants quick, easy, and affordably with our Year-End Bundles. Select packages which come once a year… these deals have been designed to fit your lab’s needs – and budget. Please note… Read more »

Headed to Houston, TX for ASHG 2019

         October 14, 2019
ASHG 2019

Our team is getting ready to head to Houston, Texas for the American Society of Human Genetics Annual Meeting (ASHG) 2019. We are looking forward to spending the week discussing genetics with new and familiar faces! If you are planning on attending, please stop by our booth and say hello! You will find the Golden Helix team in booth 601…. Read more »

Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies

         August 16, 2019
Inc 5000

Earlier this week, Inc. magazine ranked Golden Helix on the 2019 Inc. 5000 list with three-year revenue growth of 61%. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first… Read more »

On Our Way to AMP Global 2019

         May 9, 2019

We are looking forward to a great conference at AMP Global 2019: Global Congress on Molecular Pathology being held in Hong Kong! If you are attending the conference, we hope you will stop by our booth and say hello to the team! We would love the opportunity to connect with everyone within our community in person. This conference is especially… Read more »

2019 1st Place Abstract Competition Winner

         April 2, 2019
CNV calling - Abstract Winner

Mark Trinder is our 2019 Abstract Competition 1st Place Winner. As we prepare for his upcoming webcast on April 10, 2019, we wanted to give our community a little bit of a background on him! Mark Trinder is an MD/Ph.D. student at the University of British Columbia, Canada working under the supervision of Dr. Liam Bruham. Mark’s research focuses on… Read more »

Recent Customer Publications

         March 12, 2019
customer

This year has been full of excitement for our team, and customers as well; we have a plethora of recently published articles citing Golden Helix! We would like to congratulate everyone on their success. Please enjoy these features articles, or see the full list here. SNP & Variation Suite Di Gerlando, R.; Mastrangelo, S.; Sardina, M.T.; Ragatzu, M.; Spaterna, A.;… Read more »

Case Study: Odense University Hospital

         February 7, 2019

The Department of Clinical Genetics at Odense University Hospital offers a variety of genetic analyses for families of syndromic children and other inherited conditions, averaging 4,000 genetic analyses per year. In 2016, the lab decided to introduce whole exome sequencing to their offerings to take over a lot of the work they were currently conducting via gene panel analysis. They… Read more »